Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Tumori|April 3, 2019
Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinibSnjezana Janjetovic, Anne Marie Asemissen, Frank Dicker, et al.
Leukemia & Lymphoma|July 24, 2018
A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cellsAnna Brandt, Jakob Matschke, Wilfried Fehrle, et al.
Blood Cancer Journal|March 31, 2022
Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21<sup>R110</sup> chronic lymphocytic leukemiaLisa Paschold, Donjete Simnica, Ramon Benitez Brito, et al.
Annals of Hematology|June 5, 2015
Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM typeMinna Voigtlaender, Birthe Vogler, Martin Trepel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2015
Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins"Elmar Spies, Michael Fichtner, Fabian Müller, et al.
Cancer Research|April 19, 2007
Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumabMascha Binder, Friederike-Nora Vögtle, Stefan Michelfelder, et al.
Cancers|October 13, 2021
RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and PrognosisFranziska Lea Schümann, Marcus Bauer, Elisabeth Groß, et al.
Homeopathy : the Journal of the Faculty of Homeopathy|December 1, 2009
Isopathic treatment effects of Arsenicum album 45x on wheat seedling growth--further reproduction trialsLisa Lahnstein, Mascha Binder, André Thurneysen, et al.
Oral Oncology|January 30, 2022
Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HNHanna Jonas, Donjete Simnica, Lara Bußmann, et al.
Frontiers in Oncology|August 8, 2022
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 InhibitionLuise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Tumori|April 3, 2019
Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinibSnjezana Janjetovic, Anne Marie Asemissen, Frank Dicker, et al.
Leukemia & Lymphoma|July 24, 2018
A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cellsAnna Brandt, Jakob Matschke, Wilfried Fehrle, et al.
Blood Cancer Journal|March 31, 2022
Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21<sup>R110</sup> chronic lymphocytic leukemiaLisa Paschold, Donjete Simnica, Ramon Benitez Brito, et al.
Annals of Hematology|June 5, 2015
Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM typeMinna Voigtlaender, Birthe Vogler, Martin Trepel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2015
Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins"Elmar Spies, Michael Fichtner, Fabian Müller, et al.
Cancer Research|April 19, 2007
Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumabMascha Binder, Friederike-Nora Vögtle, Stefan Michelfelder, et al.
Cancers|October 13, 2021
RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and PrognosisFranziska Lea Schümann, Marcus Bauer, Elisabeth Groß, et al.
Homeopathy : the Journal of the Faculty of Homeopathy|December 1, 2009
Isopathic treatment effects of Arsenicum album 45x on wheat seedling growth--further reproduction trialsLisa Lahnstein, Mascha Binder, André Thurneysen, et al.
Oral Oncology|January 30, 2022
Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HNHanna Jonas, Donjete Simnica, Lara Bußmann, et al.
Frontiers in Oncology|August 8, 2022
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 InhibitionLuise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, et al.
Pageof 17